Vertex Pharmaceuticals Inc (VRTX) Com Stk
Sell:$393.32Buy:$393.50
$2.86 (0.73%)
NASDAQ:
0.52%
Market closed | Prices delayed by at least 15 minutes0.52%- This stock can be held in a
Stocks and Shares ISASell:$393.32
Buy:$393.50
Change:$2.86 (0.73%)
$2.86 (0.73%)Market closed | Prices delayed by at least 15 minutes
Sell:$393.32
Buy:$393.50
Change:$2.86 (0.73%)
$2.86 (0.73%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 2 April 2024 | Kristen AmbroseChief Accounting Officer | Sell Regular sell transaction (market) | 240 | $419.00 | $100,560.00 | 7,500 |
| 1 April 2024 | Kristen AmbroseChief Accounting Officer | Sell Tax related | 225 | $418.10 | $94,072.50 | 7,740 |
| 26 February 2024 | Ourania (Nia) TatsisExecutive Vice President | Sell Regular sell transaction (market) | 354 | $425.70 | $150,697.80 | 55,804 |
| 26 February 2024 | Amit K. SachdevExecutive Vice President | Sell Regular sell transaction (market) | 3,004 | $425.70 | $1,278,802.80 | 55,325 |
| 26 February 2024 | Stuart A ArbuckleCOO | Sell Regular sell transaction (market) | 5,034 | $425.70 | $2,142,973.80 | 49,691 |
| 26 February 2024 | David AltshulerChief Level Officer | Sell Regular sell transaction (market) | 4,239 | $425.70 | $1,804,542.30 | 25,813 |
| 26 February 2024 | Edward Morrow III AtkinsonCTO | Sell Regular sell transaction (market) | 883 | $425.70 | $375,893.10 | 15,972 |
| 26 February 2024 | Kristen AmbroseChief Accounting Officer | Sell Regular sell transaction (market) | 883 | $425.70 | $375,893.10 | 7,965 |
| 23 February 2024 | Reshma KewalramaniPresident/CEO | Sell Tax related | 9,386 | $431.79 | $4,052,780.94 | 136,507 |
| 23 February 2024 | Amit K. SachdevExecutive Vice President | Sell Tax related | 2,469 | $431.79 | $1,066,089.51 | 58,329 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 15 December 2023 | Reshma KewalramaniPresident/CEO | Sell Option/Award related | 17,135 | $407.00 | $6,973,945.00 | 108,711 |
| 13 December 2023 | Jeffrey M LeidenExecutive Chairman | Sell Regular sell transaction (market) | 13,254 | $399.41 | $5,293,780.14 | 9,171 |
| 16 October 2023 | Jeffrey M LeidenExecutive Chairman | Sell Regular sell transaction (market) | 12,962 | $374.00 | $4,847,788.00 | 22,425 |
| 6 November 2023 | Bruce I SachsIndependent Director | Sell Option/Award related | 11,250 | $385.00 | $4,331,250.00 | 40,000 |
| 23 February 2024 | Reshma KewalramaniPresident/CEO | Sell Tax related | 9,386 | $431.79 | $4,052,780.94 | 136,507 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.